Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancer.

MLA

Shiono, Ayako, et al. “Real-World Data of Atezolizumab plus Carboplatin and Etoposide in Elderly Patients with Extensive-Disease Small-Cell Lung Cancer.” Cancer Medicine, vol. 12, no. 1, Jan. 2023, pp. 73–83. EBSCOhost, https://doi.org/10.1002/cam4.4938.

APA

Shiono, A., Imai, H., Wasamoto, S., Tsuda, T., Nagai, Y., Minemura, H., Yamada, Y., Kishikawa, T., Umeda, Y., Takechi, H., Yamaguchi, O., Mouri, A., Kaira, K., Taniguchi, H., Minato, K., & Kagamu, H. (2023). Real-world data of atezolizumab plus carboplatin and etoposide in elderly patients with extensive-disease small-cell lung cancer. Cancer Medicine, 12(1), 73–83. https://doi.org/10.1002/cam4.4938

Chicago

Shiono, Ayako, Hisao Imai, Satoshi Wasamoto, Takeshi Tsuda, Yoshiaki Nagai, Hiroyuki Minemura, Yutaka Yamada, et al. 2023. “Real-World Data of Atezolizumab plus Carboplatin and Etoposide in Elderly Patients with Extensive-Disease Small-Cell Lung Cancer.” Cancer Medicine 12 (1): 73–83. doi:10.1002/cam4.4938.